A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PNU-100480 (PF-02341272) After Administration Of Multiple Escalating Oral Doses To Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2013
At a glance
- Drugs Sutezolid (Primary) ; Linezolid; Pyrazinamide
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 12 Sep 2010 Results presendted at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 29 Jun 2010 Actual patient number (59) added as reported by ClinicalTrials.gov.
- 29 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.